Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep;31(9):101723.
doi: 10.1016/j.jsps.2023.101723. Epub 2023 Jul 31.

Appropriateness of proton pump inhibitors use in noncritically ill hospitalized children in a tertiary hospital in Saudi Arabia

Yousif A Alosaily  1 , Jawaher M Alfallaj  2 , Juman S Alabduljabbar  2 , Elham F Alfehaid  2 , Osamah M Alfayez  3 , Mohammedelbagir Elrasheed  4
Affiliations

Appropriateness of proton pump inhibitors use in noncritically ill hospitalized children in a tertiary hospital in Saudi Arabia

Yousif A Alosaily et al. Saudi Pharm J. 2023 Sep.

Abstract

Background: Studies assessing the appropriate use of proton pump inhibitors (PPIs) for hospitalized noncritically ill pediatric patients are lacking. Therefore, this study aimed to assess the suitability of PPI prescriptions in noncritically ill pediatric patients.

Methods: This cross sectional retrospective study was conducted at a maternity hospital in Qassim, Saudi Arabia from November 2020 to January 2021. All noncritically ill hospitalized children aged 14 years and below who received PPIs were included. The endpoints included the number and percentage of patients who appropriately received PPIs in general and in each age category. The collected data were analyzed using Microsoft Excel (version 2208, Microsoft Corp., Redmond, WA, USA).

Results: In total, 332 medical records were screened, of which 246 were included. Of all patients, 49.2% were children and 50.8% were infants, with the average age at admission being 5.39 ± 5.4 years years. More than half of the patients were female, and the average weight of patients was 19.8 kg. Omeprazole was appropriately used in 95 (38.5%) patients. Based on age groups, omeprazole was appropriately used in 66.3% of children and 38.4% of infants.

Conclusion: The use of omeprazole in noncritically ill pediatrics was only deemed appropriate in 38.6% of the study population. This result indicates that this medication was overused in the institution. Additional research is required to confirm this on a nationwide scale.

Keywords: Child; Cross-sectional study; Hospitalization; Infant; Omeprazole; Pediatric; Proton pump inhibitor.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Similar articles

See all similar articles

Cited by

  • Safety of Proton Pump Inhibitors in Pediatric Population: A Systematic Review.
    Alla D, Shah DJ, Seepana M, Salian RB, Alla SSM, Krishna Mohanan M, Sabıroğlu M, Vegesna MSS, Singh A, Gupta S, Shivalingappa Rekha S. Alla D, et al. Glob Pediatr Health. 2024 Apr 29;11:2333794X241248967. doi: 10.1177/2333794X241248967. eCollection 2024. Glob Pediatr Health. 2024. PMID: 38685999 Free PMC article. Review.

References

    1. Abu El-Ella S.S., Said El-Mekkawy M., Mohamed Selim A. Stress ulcer prophylaxis for critically ill children: Routine use needs to be re-examined. Anales de pediatria. 2021 doi: 10.1016/j.anpedi.2020.12.023. - DOI - PubMed
    1. Aihara T., Nakamura E., Amagase K., Tomita K., Fujishita T., Furutani K., Okabe S. Pharmacological control of gastric acid secretion for the treatment of acid-related peptic disease: past, present, and future. Pharmacol. Ther. 2003;98(1):109–127. doi: 10.1016/s0163-7258(03)00015-9. - DOI - PubMed
    1. Akkawi M.E., Elnaem M.H. Evaluation of the prescribing of proton pump inhibitors as stress ulcer prophylaxis for non-ICU patients in a Malaysian tertiary hospital. Drugs Ther. Perspectives. 2020;36(11):529–534. doi: 10.1007/s40267-020-00770-6. - DOI
    1. Alsultan M.S., Mayet A.Y., Malhani A.A., Alshaikh M.K. Pattern of intravenous proton pump inhibitors use in ICU and Non-ICU setting: a prospective observational study. Saudi J. Gastroenterol.: Off. J. Saudi Gastroenterol. Assoc. 2010;16(4):275–279. doi: 10.4103/1319-3767.70614. - DOI - PMC - PubMed
    1. Arriola V., Tischendorf J., Musuuza J., Barker A., Rozelle J.W., Safdar N. Assessing the risk of hospital-acquired clostridium difficile infection with proton pump inhibitor use: a meta-analysis. Infect. Control Hosp. Epidemiol. 2016;37(12):1408–1417. doi: 10.1017/ice.2016.194. - DOI - PMC - PubMed

LinkOut - more resources